CytRx Total Liabilities 2010-2022 | CYTR

CytRx total liabilities from 2010 to 2022. Total liabilities can be defined as the total value of all possible claims against the corporation.
CytRx Annual Total Liabilities
(Millions of US $)
2021 $4
2020 $3
2019 $2
2018 $3
2017 $30
2016 $38
2015 $23
2014 $18
2013 $31
2012 $10
2011 $14
2010 $6
2009 $7
CytRx Quarterly Total Liabilities
(Millions of US $)
2022-03-31 $3
2021-12-31 $4
2021-09-30 $3
2021-06-30 $3
2021-03-31 $3
2020-12-31 $3
2020-09-30 $5
2020-06-30 $3
2020-03-31 $3
2019-12-31 $2
2019-09-30 $3
2019-06-30 $2
2019-03-31 $2
2018-12-31 $3
2018-09-30 $10
2018-06-30 $19
2018-03-31 $22
2017-12-31 $30
2017-09-30 $28
2017-06-30 $39
2017-03-31 $38
2016-12-31 $38
2016-09-30 $40
2016-06-30 $37
2016-03-31 $42
2015-12-31 $23
2015-09-30 $13
2015-06-30 $20
2015-03-31 $22
2014-12-31 $18
2014-09-30 $19
2014-06-30 $23
2014-03-31 $17
2013-12-31 $31
2013-09-30 $13
2013-06-30 $9
2013-03-31 $11
2012-12-31 $10
2012-09-30 $21
2012-06-30 $27
2012-03-31 $19
2011-12-31 $14
2011-09-30 $16
2011-06-30 $7
2011-03-31 $9
2010-12-31 $6
2010-09-30 $7
2010-06-30 $6
2010-03-31 $7
2009-12-31 $7
2009-09-30 $7
2009-06-30 $10
2009-03-31 $13
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.006B $0.000B
CYTRX CORP. is engaged in the development and commercialization of pharmaceutical related products and services including human therapeutics focused on high-value critical- care therapies.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $162.213B 9.87
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.280B 16.23
Biohaven Pharmaceutical Holding (BHVN) United States $10.017B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.593B 0.00
Emergent Biosolutions (EBS) United States $1.775B 7.60
Arcus Biosciences (RCUS) United States $1.357B 34.40
Myovant Sciences (MYOV) United Kingdom $1.000B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.486B 0.00
Gelesis Holdings (GLS) United States $0.360B 0.00
Zymeworks (ZYME) Canada $0.346B 0.00
Ambrx Biopharma (AMAM) United States $0.149B 0.00
Enzo Biochem (ENZ) United States $0.116B 23.80
SQZ Biotechnologies (SQZ) United States $0.099B 0.00